TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change From Baseline in Height Adjusted Total Kidney Volume (htTKV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of clinically cured patients with severe COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Number of clinically cured patients with mild COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Number of healthy people who are not infected with COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Evaluation of first rank symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver Biomarkers expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 20% improvement based on ACR responder criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: [18F]FDG diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cough apart from colds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Exercise-induced dyspnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduced lung function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in frequency of voiding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Patient Perception of Bladder Condition (PPBC)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in motivation for medication adherence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Immune modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from Baseline body weight gain at 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of cancer related fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of cancer related fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Recruitment rate of at least 6 patients per month
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of On-treatment Pregnancies (Pearl Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Improvement of periodontal condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aneurysm Clip Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Vaginal Cytokine Expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean daily delay of tablet release
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safe Sleep Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants with pleural effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total Postpartum Blood Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to hemostasis following vessel access site closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to ambulation following vessel access site closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined rate of closure related major adverse events at 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Susceptibility to pulmonary tuberculosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Detection of Expiratory Flow Limitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of Participants reaching objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in motor unit number estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Musculoskeletal Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: 2-year Event-free Survival (EFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Serial blood counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement of IKDC score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 30-day complication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: impact on quality-of-life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Correctness of carbohydrate counting answers
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improved Clinical Benefit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of HbA1c Level From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of Body Weight From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Treatment emergent ADA incidence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute Weighted Mean of Forced Expiratory Volume in 1 Second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change From Baseline in Mean Pre-dose Morning Peak Expiratory Flow (AM PEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes of tooth color
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: arterial CO2 partial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived benefit of HEAD START use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of Grade 3 or higher adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in functional autonomy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pseudoarthrosis Radiographic Healing Score (PRHS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in MDA levels in GCF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Placebo-subtracted change of the QTc interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of dilations needed after randomization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: sensitivity of the VOCAL test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of the VOCAL test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive predictive value (PPV) of the VOCAL test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: negative predictive value (NPV) of the VOCAL test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in apelin mediated vasodilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants with acute adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with late adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: sCD23 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disabilities of Arm, Shoulder and Hand Score (DASH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Concussion reporting intention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reproductive hormones concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of Severe Hypoglycaemic Episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 3 Dimensional Kinematic Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Safety Assessment
Endpoint domain: Adverse events/effects
Primary endpoint: Proprioception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dermal and epidermal nerve fiber densities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Free walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severe arrhythmias with hemodynamic compromise or pacemaker implant or Implantable cardiac defibrillator
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in trait anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite of all-cause mortality or stroke rates
Endpoint domain: Mortality/survival
Primary endpoint: Delayed bleeding requiring hemostasis after polypectomy
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Time in Target Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Developmental outcome of school-age children
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Residual Platelet Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of MRSA infections
Endpoint domain: Adverse events/effects
Primary endpoint: Regional Alveolar Oxygen Tension Heterogeneity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Apparent Diffusion Coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Specific Ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Knee mechanics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bridging trabecular bone scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Birth of baby before 34 weeks of gestation
Endpoint domain: Mortality/survival
Primary endpoint: Alcohol use measured by Timeline Followback (TLFB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alcohol levels measured by PEth blood alcohol testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication adherence measured by Wisepill adherence counts
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Injection Site Pain
Endpoint domain: Adverse events/effects
Primary endpoint: Failure of Therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Androgen hyper-responsiveness to insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Volumetric growth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of dialysis access
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Relief from gastrointestinal disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean change from baseline score of Immune Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change in neurocognitive measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in Average Daily Subject-reported Total Nasal Symptom Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in muscle glucose transporter expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensitivity of the SEM Scanner Device for Detecting Early Pressure Ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Specificity of the SEM Scanner Device for Detecting Early Pressure Ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in CD27+ B-cell frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area under the cortisol concentration time curve from 0 to 3 hours (AUC(0-3))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Carotid Intima Medial Thickness (CIMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy of topical anesthetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fluoride concentration of saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of NTSS-6 SCORE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wheelchair Skills Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak of thrombin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: lag time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: time to peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: VAS index indicating pain value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in maximum mouth opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Facial Landmark Length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in genetic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of short chain fatty acids in plasma and urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mode of relapse detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-term change in cardiorespiratory fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Long-term change in cardiorespiratory fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in Quality of Life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area under the curve (AUC) of plasma concentration (CP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absorption rate Cpmax/AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary target patency at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Total opioid consumption for 24 hours
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Post Procedure Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wear rates of polyethylene
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tooth Impression Grading Score Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Testicular position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to effectively ripen cervix
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of patients with correct TNM staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First Heart Failure Hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Protein intake of the subject
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Distribution of sarcopenia subject in the institutionalized elderly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characteristic of handgrip strength subject
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characteristic of physical performance subject
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association of protein intake with sarcopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C5 (Provocant concentration eliciting at least 5 coughs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Baseline startle magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Affective modulation of the startle magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of RV dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of resected and metastatic lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Gastrointestinal Anatomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Study Recruitment Rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Participants Who Completed All Study Visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Green tea catechin concentration levels in prostate tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum plasma concentration (Cmax) for saxagliptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) for metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under plasma concentration time curve (AUC) for saxagliptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under plasma concentration time curve (AUC) for metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of treatment failures
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Bayley-III-NL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain measured by visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of Irbesartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of Atorvastatin and 2-hydroxy atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Irbesartan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of Atorvastatin and 2-hydroxy atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's functional status using WOMAC total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Location of ACL grafts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Visibility of ACL grafts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost during the 2 postoperative years
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Patients With Abdominal Recurrence or Death
Endpoint domain: Mortality/survival
Primary endpoint: Changes in temperature of pixels on the upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in expiratory volume flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Buttonhole survival
Endpoint domain: Mortality/survival
Primary endpoint: Penetration of RO5323441 into recurrent GBM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of RO5323441
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of grade 3 or 4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Combined rate of failure at the end of treatment and relapse during the subsequent 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Hemorrhagic Events Requiring Medical Intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Investigator's Global Assessment of Redness (IGA-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose of medication deposited in the lungs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pouch emptying rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants with self-reported outcome data
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of missing data in patient outcome questionnaires
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Appropriateness of patient outcome questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Procedure-related Complication-free Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Acute Success Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Estimated volume of the upper limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Organ Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTTs and CSTTs assessed by TEMPtest 3.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes